Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 06/06/19961 min de leitura
Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the following changes to its Orphan Products Development (OPD) grant program for fiscal year (FY) 1997. The previous announcement of this program, which was published in the Federal Register of August 15, 1994, is superseded by this announcement. In the future, a new announcement will be published annually. This and future announcements will provide the programmatic requirements and criteria, as well as the two dates for receipt of applications, the estimated amount of funds available, and the estimated number of awards to be made in each FY.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →